Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S4W-19956 · Session 4

What savings it anticipates in the medicines budget in each of the next five years as a result of (a) the introduction of the Pharmaceutica…

Answered Asked by Dr Richard Simpson Lab Lodged 26 Feb 2014

The question

To ask the Scottish Government what savings it anticipates in the medicines budget in each of the next five years as a result of (a) the introduction of the Pharmaceutical Price Regulation Scheme agreement in January 2014 and (b) branded products coming out of patent and becoming available as generic products.

The answer

Answered by Alex Neil on 6 Mar 2014 · 8 days after it was lodged, on time

The Pharmaceutical Price Regulation Scheme (PPRS) came into force on 1 January 2014. The scheme was agreed by the Department of Health in England and the Association of the British Pharmaceutical Industry (ABPI). Devolved administrations requested inclusion in the negotiations but were refused.
The PPRS in place from 1 January 2014 operates differently from the previous scheme. The key aspect for the Scottish Government is ensuring that the mechanism in the scheme agreed by the UK Government and ABPI provides a fair return for Scotland. Discussions are ongoing between the four nations and have not yet concluded.
It is not possible to estimate with certainty the level of savings which may be achieved as generic versions become available for branded drugs whose period of patent protection is expected to expire. This is because it is not known in advance how many generic manufacturers will choose to offer versions of the drugs in question, the prices at which such drugs will be offered, or what other contingent market impact there may be. Over the last 10 years there has been a shift away from developing new medicines for primary care and towards those for treating rare conditions and cancer. This means that from 2013-14 until 2017-18 and beyond there are far fewer primary care medicines with patent protection due to expire.

In the Official Report

No contribution in the Official Report cites S4W-19956 by reference.